Anzeige
Mehr »
Dienstag, 01.07.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 853849 | ISIN: JP3463000004 | Ticker-Symbol: TKD
Tradegate
01.07.25 | 08:25
25,910 Euro
-1,41 % -0,370
Branche
Chemie
Aktienmarkt
NIKKEI-225
Singapur
1-Jahres-Chart
TAKEDA PHARMACEUTICAL CO LTD Chart 1 Jahr
5-Tage-Chart
TAKEDA PHARMACEUTICAL CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
25,81026,05009:06
25,79026,05009:06

Aktuelle News zur TAKEDA PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
TAKEDA PHARMACEUTICAL Aktie jetzt für 0€ handeln
MoTakeda survey finds colon cancer patients feel unheard by HCPs, want more info on diagnosis, treatment4
MoFDA Approves Takeda's Gammagard Liquid ERC4
MoFDA Approves Takeda's GAMMAGARD LIQUID ERC For Primary Immunodeficiency235TOKYO (dpa-AFX) - Takeda Pharmaceutical Company Limited (TAK) Monday said that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID ERC, a ready-to-use liquid immunoglobulin...
► Artikel lesen
MoTAKEDA PHARMACEUTICAL COMPANY LIMITED: GENERAL ANNOUNCEMENT::2025 ANNUAL INTEGRATED REPORT7
FrTurnstone, once allied with AbbVie and Takeda, accepts $8M Xoma buyout11
MiADMA vs Takeda: Which Plasma Therapy Stock Is the Better Buy Today?10
MiTAKEDA PHARMACEUTICAL CO LTD - 20-F, Annual and transition report of foreign private issuers8
MiTAKEDA PHARMACEUTICAL CO LTD - 6-K, Report of foreign issuer3
MiTAKEDA PHARMACEUTICAL COMPANY LIMITED: GENERAL ANNOUNCEMENT::TAKEDA ANNOUNCES NEW ASSIGNMENTS OF DIRECTORS3
MiTAKEDA PHARMACEUTICAL COMPANY LIMITED: GENERAL ANNOUNCEMENT::NOTICE OF RESOLUTIONS AT THE 149TH ORDINARY GENERAL MEETING OF SHAREHOLDERS4
17.06.With FDA nod for HAE drug Andembry, CSL set to compete with Takeda's Takhzyro6
17.06.Takeda's VP to Quit Japanese Drugmaker to Join Chinese Rival BeiGene, Sources Say12
12.06.TAKEDA PHARMACEUTICAL COMPANY LIMITED: GENERAL ANNOUNCEMENT::SHARE REPURCHASE REPORT (FROM MAY 1, 2025 TO MAY 31, 2025)4
10.06.TAKEDA PHARMACEUTICAL COMPANY LIMITED: GENERAL ANNOUNCEMENT::NOTICE CONCERNING DISPOSAL OF TREASURY SHARES - LTIP FOR COMPANY GROUP EMPLOYEE OUTSIDE OF JAPAN4
06.06.TAKEDA PHARMACEUTICAL CO LTD - 6-K, Report of foreign issuer6
06.06.TAKEDA PHARMACEUTICAL COMPANY LIMITED: GENERAL ANNOUNCEMENT::STATEMENT CHAIR OF TAKEDA BOD IN RESPONSE TO ISS VOTING RECOMMENDATIONS AHEAD OF THE ORDINARY GMS3
05.06.EQS Newswire: Best Places to Work: Takeda Ukraine & Bulgaria Earn #8 Global Ranking in Best Places to Work 2024440EQS Newswire / 05/06/2025 / 11:30 CET/CEST LONDON, UK - Media OutReach Newswire - 5 June 2025 - Takeda, a global value-based, R&D-driven biopharmaceutical company, has been proudly recognized...
► Artikel lesen
04.06.Takeda receives EC approval for Adcetris combination in Hodgkin lymphoma15
04.06.EC approves Takeda ADC plus chemo for stage IIb Hodgkin's lymphoma10
03.06.Takeda, Pfizer's Adcetrix wins EU approval for hodgkin lymphoma treatment16
Weiter >>
149 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1